Nelfinavir and Non-Nucleoside Reverse Transcriptase Inhibitor-Based Salvage Regimes in Heavily Hiv Pretreated Patients

Lignende værker

• Dolutegravir Plus Two Nucleoside Reverse Transcriptase Inhibitors versus Efavirenz Plus Two Nucleoside Reverse Transcriptase Inhibitors As Initial Antiretroviral Therapy for People with HIV: A Systematic Review.
  af: George W Rutherford, et al.
  Udgivet: (2016-01-01)
• The impact of the recent HIV non-nucleoside reverse transcriptase inhibitors and nucleoside reverse transcriptase inhibitors-based regimens on metabolic health outcomes: A narrative review
  af: Amogelang Sedibe, et al.
  Udgivet: (2025-12-01)
• Strategies in the Design and Development of Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs)
  af: Murugesan Vanangamudi, et al.
  Udgivet: (2023-09-01)
• Lipidic strategy for improving bioavailability of nucleoside HIV reverse transcriptase inhibitor
  af: N. S. Shastina, et al.
  Udgivet: (2011-04-01)
• Multicenter study of skin rashes and hepatotoxicity in antiretroviral-naïve HIV-positive patients receiving non-nucleoside reverse-transcriptase inhibitor plus nucleoside reverse-transcriptase inhibitors in Taiwan.
  af: Pei-Ying Wu, et al.
  Udgivet: (2017-01-01)